Moderna begins phase-3 clinical trial of Covid-19 vaccine in US
Pharmaceutical company Moderna has begun a phase-3 clinical trial to evaluate an investigational vaccine known as mRNA-1273 designed to protect against Covid-19 virus.The trial, which will be conducted at the US clinical research sites,…